WeedMarketCap
Legal MapCommunity
WeedMarketCap

Cannabis market data, tracked daily.

Legal States Map 2026CommunityAboutContactPrivacy Policy

Prices may be delayed. This site is for informational purposes only and does not constitute financial advice. Cannabis stocks carry significant risk — always do your own research.

© 2026 WeedMarketCap. All rights reserved.

WeedMarketCap
Legal MapCommunity
Back to market table
TLRY logo

Unranked

Tilray Brands, Inc.

TLRY · Nasdaq

$4.515

-0.33% (24h)

Last updated: 1 second ago

Market Cap

$621.18M

Volume (24h)

1.31M

Last Close (7D)

$4.51

View on TradingView
Earnings Oct 8 · in 34d

Latest Quarter

Q3 FY2026ended 2026-02-28 · filed 2026-04-01

View 10-Q on SEC
Revenue

$206.73M

+11.28% YoY
Net Income

$-26.57M

+96.63% YoY
Operating Income

$-26.39M

+96.53% YoY
EPS (Diluted)

-$0.24

+97.24% YoY
Cash

$204.62M

Total Assets

$2.07B

Equity

$1.56B

Long-term Debt

N/A

What this quarter tells us

Tilray’s Q3 FY2026 shows a bigger top line and a much smaller loss than the same period a year earlier — but the company is still not profitable, and recent SEC filings point to ongoing share issuance.

  • •Revenue reached about $207M, up roughly 11% year over year, so the cannabis + consumer brands mix is still growing sales.
  • •The quarter was still a loss (~$26.6M net; −$0.24 diluted EPS). The huge YoY “improvement” mostly reflects how large last year’s loss was, not that Tilray has flipped to profit.
  • •Cash of about $205M and equity of about $1.6B leave a meaningful balance-sheet cushion, but losses keep drawing on that runway.
  • •Five dilution/offering-related filings in the last 12 months are a key watchpoint — existing holders should track how often new shares are sold into the market.

Informational summary based on SEC XBRL figures. Not investment advice.

Earnings reports (12m): 4Dilution / offering filings (12m): 5Source: SEC EDGAR XBRL

Company Profile

Exchange
Nasdaq
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
3,595
Website
www.tilray.com
Country
🇨🇦 Canada

The largest Canadian cannabis LP by revenue, Tilray Brands has reinvented itself as a diversified consumer goods company with craft beer, spirits, wellness brands, and global cannabis operations.

  • 🍺 Beer and spirits brands (SweetWater, Montauk, Breckenridge) now rival cannabis in total revenue
  • 🌍 Germany's largest medical cannabis supplier — positioned for upside as Europe moves toward adult-use
  • 🤝 2021 merger with Aphria created a Canadian cannabis giant with production scale and global distribution

Key Stats

52-Week Range
$3.67$23.20
Beta1.92
Trailing P/EN/A
Forward P/E10.03
Trailing EPS-1.09
Avg Volume

Earnings & Analyst

Next Earnings2026-10-08
EPS Estimate0.05
Target Mean Price$7.84
RecommendationNone
Recommendation MeanN/A

Recent SEC Filings

All filings
  • Unregistered equity sale

    Swapped $12M of 5.20% convertible notes due 2027 for about 2.64 million common shares in private debt-for-equity exchanges.

    8-K · 3.02

    2026-06-30

    SEC

  • Unregistered equity sale

    Issued about 399k shares as part of the Lyphe acquisition, and swapped another $6M of convertible notes for about 1.21 million shares.

    8-K · 3.02

    2026-06-09

    SEC

  • Other event

    Filed a counsel legal opinion and consent tied to Tilray's shelf registration for equity offerings.

Frequently Asked Questions

What does Tilray Brands (TLRY) do?

Tilray Brands is a Canadian licensed cannabis producer (LP) that has evolved into a diversified consumer goods company. Its operations span cannabis, craft beer, spirits, and wellness brands. While it remains one of the largest cannabis LPs by revenue in Canada, its beer and spirits portfolio—including SweetWater, Montauk, and Breckenridge—now generates a significant portion of total revenue. The company also has a strong presence in Europe, particularly as Germany's largest medical cannabis supplier, positioning it for potential growth as European markets move toward adult-use legalization.

What is Tilray Brands' business model?

Tilray Brands operates a diversified business model that combines cannabis cultivation and distribution with a growing portfolio of consumer packaged goods. On the cannabis side, it is a licensed producer in Canada and a leading medical cannabis supplier in Germany, with production scale and global distribution capabilities. The company also owns several craft beer and spirits brands, such as SweetWater, Montauk, and Breckenridge, which contribute significantly to its revenue. This diversification allows Tilray to mitigate risks associated with the cannabis industry while leveraging its distribution network across multiple product categories.

In which markets does Tilray Brands operate?

Tilray Brands operates primarily in Canada, the United States, and Europe. In Canada, it is one of the largest licensed cannabis producers by revenue, serving the adult-use and medical markets. In the United States, its focus is on craft beer and spirits through brands like SweetWater, Montauk, and Breckenridge. In Europe, Tilray is Germany's largest medical cannabis supplier, with a strong distribution network that positions it for potential expansion as European countries move toward adult-use cannabis legalization. The company's global operations are supported by production facilities and partnerships across these regions.

What is Tilray Brands' role in the cannabis sector?

Tilray Brands is classified as a Canadian licensed cannabis producer (LP), but it has expanded beyond traditional cannabis cultivation to become a diversified consumer goods company. It is one of the largest LPs by revenue in Canada, with a significant presence in the medical cannabis market in Europe, particularly in Germany. The company's 2021 merger with Aphria created a Canadian cannabis giant with enhanced production scale and global distribution. Additionally, its growing portfolio of craft beer and spirits brands differentiates it from pure-play cannabis companies, making it a unique player that blends cannabis and consumer packaged goods.

What are some notable brands or differentiators of Tilray Brands?

Tilray Brands stands out for its diversified brand portfolio that includes cannabis, craft beer, and spirits. Notable beer and spirits brands include SweetWater, Montauk, and Breckenridge, which now rival cannabis in total revenue. On the cannabis side, Tilray is Germany's largest medical cannabis supplier, giving it a strong foothold in Europe. The company's 2021 merger with Aphria combined two major Canadian LPs, creating production scale and global distribution capabilities. This integration allows Tilray to serve both medical and adult-use markets while leveraging its consumer goods expertise to build brand loyalty across multiple categories.

Latest News

  • SeekingAlpha · Sep 2, 2026

    High Tide: German Expansion Just Added Another Bullish Catalyst

  • SeekingAlpha · Aug 31, 2026

    Tilray Brands Looks Ready For Another Large Short Squeeze Move

  • Benzinga · Aug 28, 2026

    President And Founder Of Seabreeze Capital Partners LP Dougie Kass Posts On X "We have moved to super size $MSOS and individual cannabis stocks in the belief that a favorable rescheduling announcement will come shortly."

  • Benzinga · Aug 20, 2026

    Tilray Brands Launches Major Expansion Of Its Global Cannabis Cultivation Capacity To Meet Accelerating International Medical Cannabis Demand

  • Yahoo · Aug 13, 2026

    Montauk Brewing Company Announces New Collaboration with Morning Brew Inc.

  • SeekingAlpha · Aug 11, 2026

    Village Farms Is Undervalued As International Cannabis Revenue Hits Record Levels

4.08M
Enterprise Value$1.94B
Shares Outstanding137.58M

8-K · 8.01,9.01

2026-04-21

SEC

  • Prospectus supplement

    Opened an at-the-market program to sell up to $180M of common stock through Jefferies, TD Securities, and Roth.

    424B5

    2026-04-15

    SEC

  • Material agreement

    Entered an Open Market Sale Agreement with Jefferies, TD Securities, and Roth for the $180M ATM equity program.

    8-K · 1.01,9.01

    2026-04-15

    SEC

  • Unregistered equity sale

    Swapped $12M of 5.20% convertible notes due 2027 for about 1.88 million common shares in private exchanges.

    8-K · 3.02

    2026-04-15

    SEC

  • Quarterly report

    Filed the Q3 FY2026 10-Q: revenue about $207M (+11% YoY) with a narrower net loss of about $27M.

    10-Q

    2026-04-01

    SEC

  • Earnings results

    Released Q3 FY2026 results in a press release furnished as Exhibit 99.1.

    8-K · 2.02,9.01

    2026-04-01

    SEC

  • Acquisition / disposition

    Acquired BrewDog brewery, online/retail, and 11 brewpubs out of UK administration for about £33M (~$44M).

    8-K · 1.01,2.01,8.01,9.01

    2026-03-02

    SEC

  • Quarterly report

    Filed the Q2 FY2026 quarterly report covering the period ended November 30, 2025.

    10-Q

    2026-01-08

    SEC